Table 3
Tabular presentation for ROBIS results
| Review | Phase 2 | Phase 3 | |||
|---|---|---|---|---|---|
| 1. Study eligibility criteria | 2. Identification and selection of studies | 3. Data collection and study appraisal | 4. Synthesis and findings | 5. Risk of bias in the review | |
| Multiple CAM therapies | |||||
| 1. Perry [22] | Low | Unclear | Low | Low | Low |
| 2. Bruyas-Bertholon [23] | High | High | Unclear | High | High |
| 3. Harb [24] | High | High | Low | High | High |
| 4. Gutierrez-Castrellon [25] | Unclear | High | High | High | High |
| Manipulation therapies | |||||
| 5. Dobson [26] | Low | Low | Low | Low | Low |
| 6. Gleberzon [27] | High | High | Unclear | Unclear | High |
| 7. Carnes [28] | Low | Low | Low | High | Unclear |
| Acupuncture | |||||
| 8. Skejeie [29] | Low | Low | Low | Low | Unclear |
| Herbal medicine | |||||
| 9. Anheyer [30] | Unclear | High | Low | High | High |
| Probiotics | |||||
| 10. Sung [31] | Unclear | Low | Low | High | Unclear |
| 11. Anabrees [32] | Low | Low | Low | High | Low |
| 12. Urbanska [33] | Low | High | High | High | High |
| 13. Xu [34] | Unclear | Low | Low | Unclear | Low |
| 14. Shreck Bird [35] | High | High | Low | High | High |
| 15. Dryl [36] | High | High | Unclear | High | High |
| 16. Sung [37] | High | Unclear | Unclear | Unclear | Unclear |